Crystal polymorphs of barbital: News about a classic polymorphic system

Molecular Pharmaceutics

Volumn 11, Issue 1, 2014, Pages 338-350

  Zencirci, Neslihan ^a   Griesser, Ulrich J ^a   Gelbrich, Thomas ^a   Apperley, David C ^b   Harris, Robin K ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

barbital; crystal polymorphism; IR spectroscopy; phase transition; Raman spectroscopy; solid state NMR spectroscopy; thermal analysis; thermodynamics; X ray powder diffraction

Indexed keywords

BARBITAL; HYDROGEN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTAL; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; FREEZE DRYING; HYDROGEN BOND; INFRARED SPECTROSCOPY; MELTING POINT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; ROOM TEMPERATURE; SOLID; THERMODYNAMICS;

BARBITAL; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MAGNETIC RESONANCE SPECTROSCOPY; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN; THERMODYNAMICS; X-RAY DIFFRACTION;

EID: 84891803989     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400515f     Document Type: Article

References (70)

1. The European Pharmacopoeia Onlline (7.2), 7 th ed.; Council of Europe, European Directorate for the Quality of Medicines: Strasbourg, France, 2011.
2. Okamoto, M.; Hinman, D. J. Physical dependence produced by long duration, low dose chronic barbital treatment Subst. Alcohol Actions Misuse 1984, 5, 97-103
3. Psychotropic Substances-Report 2010: Statistics for 2009; International Narcotics Control Board: Vienna, Austria, 2010.
4. Fischer, R.; Kofler, A. Über den Polymorphismus des Veronals Arch. Pharm. 1932, 270, 207-214
5. Lindpaintner, E. Mikroskopische Untersuchungen an polymorphen Substanzen Mikrochim. Acta 1939, 27, 21-41
6. Huang, T.-Y. The identification of derivatives of barbituric acid by x-ray analysis II Acta Pharm. Int. 1951, 2, 95-106
7. Huang, T.-Y. The identification of derivatives of barbituric acid by x-ray analysis VI Acta Pharm. Int. 1953, 361-363
8. Cleverley, B.; Williams, P. P. Polymorphism in substituted barbituric acid Tetrahedron 1959, 7, 277-288
9. Brandstätter-Kuhnert, M.; Aepkers, M. Molekülverbindungen, Mischkristallbildung und neue Polymorphiefälle bei Barbituraten Microchim. Acta 1962, 50, 1055-1074
10. Brandstätter-Kuhnert, M.; Aepkers, M. Molekülverbindungen, Mischkristallbildung und neue Polymorphiefälle bei Barbituraten Microchim. Acta 1963, 51, 360-375
11. Zencirci, N.; Gelbrich, T.; Kahlenberg, V.; Griesser, U. J. Crystallization of metastable polymorphs of phenobarbital by isomorphic seeding Cryst. Growth Des. 2009, 9, 3444-3456
12. Kuhnert-Brandstätter, M.; Bachleitner-Hofmann, F. Infrared spectroscopy of barbiturates Arch. Pharm. Ber. Deut. Pharm. Ges. 1971, 304, 580-590
13. Craven, B. M.; Vizzini, E. A.; Rodrigues, M. M. The crystal structure of two polymorphs of 5,5′-diethylbarbituric acid (barbital) Acta Crystallogr., Sect. B 1969, 25, 1978-1993
14. Craven, B. M.; Vizzini, E. A. The crystal structure of polymorph IV of 5,5-diethylbarbituric acid (barbital) Acta Crystallogr., Sect. B 1971, 27, 1917-1924
15. Nogami, H.; Nagai, T.; Fukoka, E.; Yotsuyanagi, T. Dissolution kinetics of barbital polymorphs Chem. Pharm. Bull. 1969, 17, 23-31
16. Sekiguchi, K.; Kanke, M.; Nakamura, N. Dissolution behavior of solid drugs. V. Determination of the transition temperature and heat of transition between barbital polymorphs by initial dissolution rate measurements Chem. Pharm. Bull. 1975, 23, 1347-1352
17. Hollenbach, K.; Pintje-Hodi, K.; Kedvessy, G. Polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behavior, of barbital Pharmazie 1979, 34, 164-166
18. Hollenbach, K.; Mezosi, J.; Pintje-Hodi, K.; Kedvessy, G. Polymorphism of barbiturates in powders and tablets. Part 2: Infrared spectroscopy and x-ray diffractometry of barbital Pharmazie 1979, 34, 240-242
19. Hollenbach, K.; Pintje-Hodi, K. Polymorphism of barbiturates in powders and tablets. Part 3: Effect of the pressing power on the modification of barbital Pharmazie 1979, 34, 807-808
20. Hollenbach, K.; Pintje-Hodi, K.; Kedvessy, G. Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and Barbital A (modifications I and II) and their release from tablets Pharmazie 1980, 35, 32-35
21. Hollenbach, K.; Pintje-Hodi, K.; Kedvessy, G. Polymorphism of barbiturates in powders and tablets. Part 5: Dissolution of recrystallized barbital substances and their release from tablet Pharmazie 1980, 35, 95-98
22. Hollenbach, K.; Pintje-Hodi, K.; Kedvessy, G. Polymorphism of barbiturates in powders and tablets. Part 6: Properties and behavior of a spray-dried barbital preparation Pharmazie 1982, 37, 562-565
23. Grabowska, I.; Kaliszan, R. Studies on the polymorphism of barbital Pol. J. Pharmacol. Pharm. 1976, 28, 529-536
24. Burger, A.; Ramberger, R. On the polymorphism of pharmaceuticals and other molecular crystals. II Microchim. Acta 1979, 72, 273-316
25. Gelbrich, T.; Zencirci, N.; Griesser, U. J. A polymorph of butobarbital with two distinct hydrogen-bonding motifs Acta Crystallogr., Sect. C 2007, 63, o751-o753
26. Zencirci, N.; Gelbrich, T.; Apperley, D. C.; Harris, R. K.; Kahlenberg, V.; Griesser, U. J. Structural features, phase relationships and transformation behavior of the polymorphs I-VI of phenobarbital Cryst. Growth Des. 2010, 10, 302-313
27. Gelbrich, T.; Zencirci, N.; Griesser, U. J. Hydrogen-bond motifs in N-monosubstituted derivatives of barbituric acid: 5-allyl-5-isopropyl-1- methylbarbituric acid (enallylpropymal) and 1,5-di(but-2-enyl)-5-ethylbarbituric acid Acta Crystallogr., Sect. C 2010, 66, o55-o58
28. Gelbrich, T.; Rossi, D.; Griesser, U. J. 5,5-Dihydroxybarbituric acid 1,4-dioxane hemisolvate Acta Crystallogr., Sect. E 2010, 66, o1219
29. Gelbrich, T.; Rossi, D.; Häfele, C. A.; Griesser, U. J. Barbiturates with hydrogen-bonded layer and framework structures CrystEngComm 2011, 13, 5502-5509
30. Gelbrich, T.; Rossi, D.; Griesser, U. J. Tetragonal polymorph of 5,5-dichlorobarbituric acid Acta Crystallogr., Sect. E 2012, 68, o235-o236
31. Rossi, D.; Gelbrich, T.; Kahlenberg, V.; Griesser, U. J. Supramolecular constructs and thermodynamic stability of four polymorphs and a co-crystal of pentobarbital (nembutal) CrystEngComm 2012, 14, 2494-2506
32. Brandstätter, M. Isomorphie und Polymorphie bei Barbitursä urederivaten Z. Phys. Chem. 1942, 191, 227-240
33. Kofler, A. Über die Polymorphie des Veronals Mikrochemie 1947, 33, 4-7
34. Kofler, L.; Kofler, A.; Brandstätter, M. In Thermo-Mikro-Methoden; Verlag Chemie: Weinheim, Germany, 1954; p 543.
35. Willis, J. N., Jr.; Cook, R. B.; Jankow, R. Raman spectrometry of some common barbiturates Anal. Chem. 1972, 44, 1228-1234
36. Kaliszan, R.; Halkiewicz, J. IR analysis of crystalline samples of some urea derivatives Pol. J. Pharmacol. Pharm. 1975, 27, 579-587
37. McMullan, R. K.; Fox, R. O., Jr.; Craven, B. M. The neutron crystal structure at -75degreesC of polymorph II of 5,5-diethylbarbituric acid (barbital) Acta Crystallogr., Sect. B 1978, 34, 3719-3722
38. Caillet, J.; Claverie, P. On the polymorphism of barbituric acid derivatives Acta Crystallogr., Sect. B 1980, 36, 2642-2645
39. Craven, B. M.; Fox, R. O., Jr.; Weber, H.-P. The charge density in polymorph II of 5,5-diethylbarbituric acid (barbital) at 198 K Acta Crystallogr., Sect. B 1982, 38, 1942-1952
40. Chauvet, A.; De Maury, G.; Terol, A.; Masse, J. Etude thermoanalytique de substances psychotropes: V. Barbital et allobarbital Thermochim. Acta 1986, 97, 143-159
41. Fournival, J. L.; Rouland, J. C.; Céolin, R. Sur le Polymorphisme du barbital et le systeme eau-barbital J. Therm. Anal. 1987, 32, 1547-1557
42. Kofler, L.; Kofler, A. Thermo-Mikro-Methoden zur Kennzeichnung organischer Stoffe und Stoffgemische; Universitätsverlag Wagner GmbH: Innsbruck, Austria, 1954.
43. Burger, A.; Ramberger, R. On the polymorphism of pharmaceuticals and other molecular crystals. I Microchim. Acta 1979, 72, 259-271
44. Etter, M. C.; MacDonald, J. C.; Bernstein, J. Graph-set analysis of hydrogen-bond patterns in organic crystals Acta Crystallogr., Sect. B 1990, 46, 256-262
45. Bernstein, J.; Davis, R. E.; Shimoni, L.; Chang, N.-L. Patterns in hydrogen bonding: functionality and graph set analysis in crystals Angew. Chem., Int. Ed. 1995, 34, 1555-1573
46. Lewis, T. C.; Tocher, D. A.; Price, S. L. An experimental and theoretical search for polymorphs of barbituric acid: the challenges of even limited conformational flexibility Cryst. Growth Des. 2004, 4, 979-987
47. Zencirci, N.; Gelbrich, T.; Jetti, R. K. R.; Kahlenberg, V.; Griesser, U. J., unpublished results.
48. DesMarteau, D. D.; Pennington, W. T.; Resnati, G. Fluorinated barbituric acid derivatives Acta Crystallogr., Sect. C 1994, 50, 1305-1308
49. Chentli-Benchikha, F.; Declercq, J. P.; Germain, G.; Van Meerssche, M.; Bouche, R.; Draguet-Brughmans, M. Structures des oxo-3 et oxo-6 cyclobarbitals Acta Crystallogr., Sect. B 1977, 33, 2739-2743
50. Williams, P. Polymorphism of phenobarbitone. II. The crystal structure of modification III Acta Crystallogr., Sect. B 1974, 30, 12-17
51. Craven, B. M.; Cusatis, C. The crystal structure of 5-ethyl-5-(1- methylbutenyl)-barbituric acid Acta Crystallogr., Sect. B 1969, 25, 2291-2298
52. Zerkowski, J. A.; Seto, C. T.; Wierda, D. A.; Whitesides, G. M. The design of organic structures in the solid state: hydrogen-bonded molecular "tapes" J. Am. Chem. Soc. 1990, 112, 9025-9026
53. Zerkowski, J. A.; MacDonald, J. C.; Seto, C. T.; Wierda, D. A.; Whitesides, G. M. Design of organic structures in the solid state: molecular tapes based on the network of hydrogen bonds present in the cyanuric acid···melamine complex J. Am. Chem. Soc. 1994, 116, 2382-2391
54. Zerkowski, J. A.; Mathias, J. P.; Whitesides, G. M. New varieties of crystalline architecture produced by small changes in molecular structure in tape complexes of melamines and barbiturates J. Am. Chem. Soc. 1994, 116, 4305-4315
55. Babu, N. J.; Reddy, L. S.; Nangia, A. Amide-N-oxide heterosynthon and amide dimer homosynthon in cocrystals of carboxamide drugs and pyridine N-oxides Mol. Pharmaceutics 2007, 4, 417-434
56. Vishweshwar, P.; Thaimattam, R.; Jaskolski, M.; Desiraju, G. R. Supramolecular synthons based on N-H···N and C-H···O hydrogen bonds. Crystal engineering of a helical structure with 5,5-diethylbarbituric acid Chem. Commun. 2002, 1830-1831
57. Golden, E.; Argent, S. P.; Blake, A. J.; Thébault, F.; Champness, N. R. Hydrogen-bonded chains formed by 5,5-diethylbarbituric acid and bipyridyl tectons Supramol. Chem. 2012, 24, 40-47
58. Zencirci, N. Polymorphism, Isomorphism, Solvate Formation and Structural Classification of Barbiturates. Ph.D. Thesis, University of Innsbruck, 2009.
59. Lin-Vien, D.; Colthup, N. B.; Fateley, W. G.; Graselli, J. G. The Handbook of Infrared and Raman Characteristic Frequencies or Organic Molecules; Academic Press: San Diego, CA, 1991.
60. Bideau, J. P. Crystalline structure of 5-ethyl-5-butylbarbituric acid C. R. Acad. Sci., Serie C: Sci. Chim. 1971, 272, 757-760
61. Harris, R. K.; Olivieri, A. C. Quadrupolar effects transferred to spin-12 magic-angle spinning spectra of solids Prog. NMR Spectrosc. 1992, 24, 435-456
62. Harris, R. K. NMR crystallography: the use of chemical shifts Solid State Sci. 2004, 6, 1025-1037
63. Bernstein, J.; Davey, R. J.; Henck, J.-O. Concomitant polymorphs Angew. Chem., Int. Ed. 1999, 38, 3440-3461
64. Aaltonen, J.; Allesø, M.; Mirza, S.; Koradia, V.; Gordon, K. C.; Rantanen, J. Solid form screening-a review Eur. J. Pharm. Biopharm. 2009, 71, 23-37
65. Gelbrich, T.; Braun, D. E.; Ellern, A.; Griesser, U. J. Four polymorphs of methyl paraben-structural relationships and relative energy differences Cryst. Growth Des. 2013, 13, 1206-1217
66. Lemmerer, A.; Bernstein, J.; Griesser, U. J.; Kahlenberg, V.; Többens, D. M.; Lapidus, S.; Stephens, P. W. A tale of two polymorphic pharmaceuticals: pyrithyldione and propyphenazone and their 1937 co-crystal patent Chem.-Eur. J. 2011, 17, 13445-13460
67. Nichols, G.; Frampton, C. S. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution J. Pharm. Sci. 1998, 87, 684-693
68. Fucke, K.; Myz, S. A.; Shakhtshneider, T. P; Boldyreva, E. V.; Griesser, U. J. How good are the crystallisation methods for co-crystals-a comparative study of Piroxicam New. J. Chem. 2012, 36, 1969-1977
69. Berry, D. J.; Seaton, C. C.; Clegg, W.; Harrington, R. W.; Coles, S. J.; Horton, P. N.; Hursthouse, M. B.; Storey, R.; Jones, W.; Friscic, T.; Blagden, N. Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients Cryst. Growth Des. 2008, 8, 1697-1712
70. Morissette, S. L.; Almarsson, O.; Peterson, M. L.; Remenar, J. F.; Read, M. J.; Lemmo, A. V.; Ellis, S.; Cima, M. J.; Gardner, C. R. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids Adv. Drug Delivery Rev. 2004, 56, 275-300